Research ArticleCancer

Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases

See allHide authors and affiliations

Science Translational Medicine  27 May 2020:
Vol. 12, Issue 545, eaaz5387
DOI: 10.1126/scitranslmed.aaz5387

Article Information

vol. 12 no. 545

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication September 17, 2019
  • Accepted for publication April 15, 2020
  • .

Author Information

  1. Lin Zhang1,2,
  2. Jun Yao1,
  3. Yongkun Wei1,
  4. Zhifen Zhou1,
  5. Ping Li1,
  6. Jingkun Qu1,
  7. Akosua Badu-Nkansah1,
  8. Xiangliang Yuan1,
  9. Yu-Wen Huang1,3,
  10. Kazutaka Fukumura4,
  11. Xizeng Mao5,
  12. Wei-Chao Chang3,
  13. Jodi Saunus6,
  14. Sunil Lakhani6,7,
  15. Jason T. Huse4,
  16. Mien-Chie Hung3 and
  17. Dihua Yu1,2,3,*
  1. 1Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  2. 2MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
  3. 3Center for Molecular Medicine, China Medical University, Taichung 40402, Taiwan.
  4. 4Department of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  5. 5Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  6. 6Faculty of Medicine, University of Queensland, St Lucia, QLD 4072, Australia.
  7. 7Pathology Queensland, The Royal Brisbane & Women’s Hospital, Herston, QLD 4029, Australia.
  1. *Corresponding author. Email: dyu{at}mdanderson.org

Altmetric

Article usage

Article usage: May 2020 to October 2020

AbstractFullPdf
May 20202243524232
Jun 20201429690328
Jul 202080195115
Aug 20201507245
Sep 20201225749
Oct 2020902414

Stay Connected to Science Translational Medicine